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Abstract 
Dermal bioavailability is currently estimated through skin penetration studies using ex 
vivo models, which lack any measure of capillary bed function, and thus do not fully 
reproduce physiological conditions. We propose a novel strategy to mimic skin 
vascularization using newly fabricated hollow fibers made from a biocompatible 
membrane material, polystyrene, which is hydrophobic if left untreated, or 
hydrophilic when its surface polarity is modified through plasma-treatment. Caffeine 
has been well studied in skin penetration assays and was used here to determine the 
permeation properties of the hollow fibers in a novel jacketed glass bioreactor. For 
hydrophobic fibers, approximately 87.2 % of the caffeine dose did not penetrate the 
porous surface; 0.2 % of the dose was collected after 24 h (permeated through the 
pores), and therefore 12.6 % of the initial dose was suspected to block the membrane. 
For hydrophilic fibers, both the percentage of the initial dose that permeated and that 
of blocking caffeine increased to 1.2 % and 35.2 % respectively. It was concluded that 
caffeine permeated the hollow fibers at similar times of clearance to those observed in 
vivo, and therefore shows that this new model could provide a surrogate for capillary-
based clearance in in vitro skin absorption studies. 
 
Keywords: Skin penetration; tissue engineering; systemic toxicity; hollow fiber 
membranes; chemical adsorption. 
Highlights: 
 Hollow fiber membranes have been manufactured using a novel material, 
achieving a porous surface via the addition of a porogen agent.  
 The surface of hollow fiber membranes has been functionalized so their 
polarity can be tailored according to their desired application. 
 The permeation of caffeine through the fibrous structure has been measured 
for both hydrophobic and hydrophilic fibers. 
 Both the rate of permeation and the degree of blocking for hydrophilic fibers 
is much higher than those for hydrophobic fibers, suggesting the presence of 
interactions between caffeine molecules and surface functional groups. 
 The existence of spontaneous permeation constitutes an excellent starting 
point for the use of polystyrene hollow fibers as ‘pseudo-capillaries’ in skin 
vascularization.  
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1. Introduction 
The study of the absorption of different chemicals, from topical drug and cosmetic 
formulations into and through the skin is key for the assessment of their safety. This is 
important for pharmaceutical and cosmetic companies to determine how much of a 
compound enters the blood stream and therefore the rest of the body – the systemic 
dose. Delivery of certain compounds via the topical route reaching the systemic 
circulation is of particular importance, since drug delivery to the skin is well accepted 
by patients [1], as opposed to other administration methods. Additionally, consumers 
may be exposed to many products via the dermal route, from cosmetics and 
household products to pesticides. Internationally accepted guidance for skin 
penetration studies has been produced by organizations such as the Organization for 
Economic Cooperation and Development (OECD, guidelines 428 and 28) [2, 3], and 
the Scientific Committee on Consumer Safety [4]. Data generated using these 
methods are relied upon for safety decision making, both in various fields of industry 
and by regulators such as the Food and Drug Administration (FDA) in the United 
States [5]. Given the complexity and multi-functional properties of skin [6, 7], 
obtaining an accurate representation of the skin absorption process is complex, where 
the ideal would be analysis of absorption through the skin in vivo, and preferably 
human in vivo. However, there are practical and ethical issues leading to a drive in the 
reduction of in vivo animal testing [8], while in vivo human clinical studies may be 
expensive, highly regulated and require the generation of large amounts of safety data 
in advance of a study. Extrapolation from inter-species in vivo data may also prove 
challenging; when performing an in vitro assay, access to ex vivo human skin allows 
testing to be performed in the species of interest. 
Considering in vitro assays, there are technical difficulties when comparing results 
obtained using different methods, species, or ages [7]. There exist a number of in vitro 
models that aim to mimic percutaneous absorption in vivo. They are classified 
according to Howes et al. as a function of their similarities with respect to the in vivo 
situation [9]. It is worth highlighting the so-called ‘Perfused Skin Models’, which are 
regarded as the most appropriate compromise between in vivo and in vitro methods 
but are not widely used since they require surgical techniques on living animals to 
form the skin flap. Their main advantage is the presence of fully active skin 
microcirculation and metabolism [10-12], since a key aspect that hampers the 
concordance between in vivo and in vitro data is the fact that most compounds are 
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cleared via the capillary vasculature that is located near the junction between the 
epidermis and dermis [13]. Vascularization of the skin has an important role in 
percutaneous absorption, and the presence of a higher number of blood vessels in 
certain parts of the body (such as the face) allows for the rapid clearance of applied 
substances [14]. The presence of follicles or skin appendages, in general, is also 
significant: as an example, Illel et al. [15] demonstrated that in the absence of hair 
follicles, the steady-state flux and the amounts diffusing in 24 or 48 h were up to four 
times lower than in normal skin in rats. Hair follicles function as preferential 
pathways for diffusion for certain molecules. However, most routine skin penetration 
assays use dermatomed skin, which lacks any form of functional vascularization, but 
still retains the appendages, which may act as a better route than in vivo, where sebum 
flow may reduce efficiency of absorption. Dermatomed skin is used to compensate for 
the lack of active circulation, reducing the depth of the dermis through which 
penetrating compounds must pass to reach the receptor solution. The dermis is a 
water-rich compartment, and may present a significant barrier to penetration for 
lipophilic materials [6].  
One of the strategies that has been traditionally used to identify the limitations of the 
in vitro methods consists of the theoretical analysis and development of correlations 
that relate the physicochemical properties of the permeants to the mechanistic aspects 
of skin permeability [16, 17]. Some of the features that are studied and compared are 
the amount excreted as a percentage of the applied topical dose [18], the flux, 
cumulative flux, cumulative mass, and permeability [19]. The concordance between 
in vivo and in vitro data dramatically depends on the nature of the compounds that 
permeate and the liquid vehicle in which they are dissolved and dosed [20], together 
with the type and/or thickness of the skin that is used in the experimental method. It 
has been shown that there is a reasonably good prediction for a number of chemicals, 
but the difference between in vitro and in vivo results is greater for lipophilic 
molecules that are retained in the stratum corneum (lipid-rich) in the absence of 
circulation [21].  
In view of the current limitations of skin penetration techniques, the introduction of 
some form of pseudo-vascularization may offer an increase in the in vivo relevance of 
the current widely accepted in vitro technique. From a tissue engineering perspective, 
the challenge of introducing pseudo-vascularization in skin models can be tackled in 
broadly two ways. Tissue engineering as a discipline involves the application of 
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engineering and life sciences principles to create biological tissue substitutes, in the 
form of full organs for instance, to restore, maintain or improve tissue function [22]. 
One of the most common strategies used in tissue engineering is the construction of 
scaffolds that allow cultivation of tissue cells in a three-dimensional environment, 
where they have access to efficient nutrition and release of waste products. Some 
examples of the application of tissue engineering can be found in the area of bone 
regeneration [23, 24], culture of liver cells [25, 26], and particularly relevant for skin 
vascularization and angiogenesis, some biomaterials have been developed to induce 
growth of new blood vessels [27]. Our approach faces the same challenge as that 
presented in the work by Gigliobianco et al. [27], e.g. the limitations due to the lack 
of vascularization in in vitro models, but aiming to include completely artificial blood 
vessels, formed by hollow fibers. Hollow fibers have been shown to be an excellent 
tool in tissue engineering applications [28-30], and the basis of this work consists of 
the inclusion of such hollow fibers as ‘pseudo-capillaries’ in in vitro skin absorption 
models. Here we aim to investigate, as a proof of concept, the characterization of 
polymeric hollow fiber membranes in terms of caffeine permeability, and the 
influence of their surface polarity on the caffeine flux that enters the pores located on 
their outer surface and is carried through their lumen mimicking the blood flow. 
Caffeine was used as a standard compound in percutaneous permeation, as indicated 
by the OECD guidelines 428 and 28 [2, 3]. This will establish the basic technology 
that can potentially be added to the current in vitro skin permeation models for an 
improved representation of in vivo clearance. 
 
2. Materials and methods 
2.1. Materials 
Caffeine powder (ReagentPlus®), sodium chloride, and polystyrene (as nurdles, 
average MW ~280,000) were purchased from Sigma-Aldrich (Dorset, UK). 1-Methyl-
2-pyrollidone was purchased from Acros Organics (Fisher Scientific, Loughborough, 
UK). 
 
2.2. Hollow fiber fabrication 
Casting dopes were formulated using 10 g of polystyrene, and 4 g of NaCl crystals of 
defined and controlled size, as described by Argyle at al. [31]. Initially, the salt 
crystals were dispersed in 19.45 ml of n-methyl-2-pyrollidone (NMP) overnight, and 
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the polymer was then added to the salt-solvent mixture, and incubated at 37 °C, 
continuously mixed for 24 hours until fully incorporated. The relative salt mass to 
polymer mass is 40 %; hence the hollow fibers in this work are referred to as PX40 
fibers for simplicity. Hollow fibers were prepared by the wet spinning technique as 
described elsewhere [28]. The tank containing the polymer was well mixed prior to 
spinning in order to ensure uniform salt dispersion. Reverse osmosis (RO) water was 
used as the coagulant. Once the spinning process was terminated, the hollow fibers 
were immersed in RO water, which was changed every 12 hours for 3 days in order to 
completely remove both the solvent and salt creating a porous structure. 
 
2.3. Hollow fiber characterization 
Morphological characterization and qualitative analysis of the porosity of PX40 fibers 
were performed using scanning electron microscopy (SEM). The fibers were 
immersed in liquid nitrogen and cut into small pieces of approximately 5 mm in 
length, prior to freeze-drying overnight. They were then sputter-coated with gold 
(Edwards Sputter Coater 5150B) and analyzed by SEM (JEOL JSM-6480LV) with an 
acceleration voltage of 10 kV. SEM micrographs of the inner and outer surfaces and 
the cross-sections of the hollow fibers were obtained.  
2.4. Hollow fiber surface modification 
PX40 fibers are intrinsically hydrophobic as demonstrated by Argyle et al. [31] via 
measurements of contact angle. However, their surface polarity can be modified. 
After the fibers were dried, they were subjected to low pressure oxygen plasma 
treatment for five minutes (25 W) using a ZEPTO Plasma cleaner (Deiner Electronic) 
in order to modify the functional groups that are present on the polymer surface, 
increasing its hydrophilicity.  
 
2.5. Caffeine permeation studies 
To determine the permeation of caffeine from the outer porous surface of PX40 
hollow fibers to their lumen – mimicking the process that occurs in capillary blood 
vessels – a custom-made glass bioreactor was designed, which allows for temperature 
control (Figure 1).  
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Figure 1: Caffeine permeation bioreactor system set-up.  
(A) Technical drawing of the hollow fiber bioreactor, including all dimensions (in mm). (B) Two-
dimensional view of the hollow fiber bioreactor. Arrows represent the flow of the different 
components. (C) Three-dimensional view of the hollow fiber bioreactor. The hollow fiber is 
placed within the inner glass tube. A single caffeine dose is introduced in the extra-capillary 
space. The outer glass tube constitutes the jacket through which water at 32 °C is recirculated in 
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order to maintain a constant temperature. Deionized (DI) water is pumped within the lumen of 
the fiber, carrying the caffeine that permeates across its porous surface. The inset represents a 
frontal view.  
 
It consisted of an inner glass tube where the hollow fiber was placed, and an outer 
jacket that was connected to a water bath in order to maintain a constant temperature. 
Since in the standard skin permeation experiments currently used in industry the skin 
surface is at 32 °C, as is the receptor fluid, the temperature of the water bath was set 
at 32 °C, and water was constantly recirculated at a flow rate of approximately 1.2 
liters min-1.  Heat losses in the tubing and through the glass walls were considered 
negligible. A single dose of 0.5 ml caffeine solution (7.5 mg ml-1) was incorporated in 
the inner glass tube, i.e. completely filling the extra-capillary space around the PX40 
fiber. A constant flow of deionized water was circulated through the lumen of the 
fiber at a flow rate of 2.5 ml h-1 (which corresponds to a mean velocity of 3.4 cm min-
1, or 0.6 mm s-1, given that the diameter of the hollow fiber is approximately 1 mm). 
This flow rate was selected in order to reproduce the conditions that are normally 
used in the conventional flow cells in skin penetration assays [32, 33], and it is within 
the range that has historically been measured for capillary blood cell velocities [34, 
35]. A flow rate of 2.5 ml h-1 is considered high enough to create sink conditions and 
thus diffusion is unconstrained by the creation of high local concentrations [7].  
The design of the custom-made glass bioreactor allows for multiple fibers (up to three 
in parallel). In this particular case, it contained a single hollow fiber of 10 cm in 
length, with an extra 2 cm on each side as shown in Figure 1. The additional length of 
both sides was not subject to permeation, as it was not in contact with the dose 
solution. The choice of a single hollow fiber was based on the equivalent surface area 
covered by the blood capillary loops that sit between the dermis and epidermis in a 
skin disk of approximately 0.45 cm radius (surface area 63.6 mm2), which is the 
standard disk size in skin penetration cells [36]. The geometrical properties of the 
capillaries were extracted from the work by Kretsos et al. [37] and summarized in 
Table 1. 
 
Table 1: Geometrical properties of dermal capillaries (adapted from [37]). 
Property Value 
Length of loop 5 x 10-4 m 
Radius 1.5 x 10-6 m 
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Capillary density 108 capillaries per m2 
 
The length of loop was considered for calculations, since it is the part of the capillary 
that is potentially in direct contact with the substance that penetrates the skin in the 
first place. The number of capillaries and the total surface area (SA) that would 
hypothetically exist in the skin disk is shown in Equations 1 and 2 respectively. 
 
𝑛𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠 =
108𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠
𝑚2
× 6.36 × 10−5𝑚2 = 6.36 × 103 𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠 Equation 1   
𝑆𝐴𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠 = 𝑛𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠 2 𝜋 𝑟𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠  𝐿𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 = 3.0 × 10
−5𝑚2        Equation 2 
 
Where ncapillaries is the number of blood capillaries (-) in the 0.45 cm-radius skin disk, 
SAcapillaries is the total surface area available for absorption (m
2), rcapillary is the radius 
of the capillary loop (m), and Lcapillary is the length of the capillary loop (m). 
 
The total surface area shown in Equation 2 was matched with the surface area 
available for permeation in the hollow fibers, taking into account the properties of 
PX40 fibers (shown in Table 2).  
 
Table 2: Geometrical properties of PX40 hollow fibers. 
Property Value 
Porosity 0.1 
Radius 485 x 10-6 m 
 
The length of the hollow fiber was therefore calculated according to Equation 3. 
 
𝐿𝑓𝑖𝑏𝑒𝑟 =
𝑆𝐴𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑖𝑒𝑠
2 𝜋 𝑟𝑓𝑖𝑏𝑒𝑟 𝛾𝑓𝑖𝑏𝑒𝑟
≈ 10 𝑐𝑚                 Equation 3 
 
Where Lfibre is the length of the hollow fiber (m), SAcapillaries is the total surface area 
available for absorption (m2), rfiber is the radius of the hollow fiber (m) and fiber is the 
porosity of the hollow fiber (-). 
 
Samples from the lumen outlet were taken every ten minutes for two hours, and in a 
second experiment every hour for 24 hours, and the concentration of caffeine was 
analyzed via HPLC (Agilent Technologies, 1260 Infinity Series). The concentration 
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of caffeine was calculated directly comparing the area of the peaks measured via 
HPLC with the calibration curve obtained with caffeine standards of known 
concentration. The integration of the peaks was performed manually. A C18 column 
was used (Poroshell 120 EC-C18, 2.7 m, 4.6 x 50 mm), and isocratic elution was 
chosen. The mobile phase was 75:25 acetonitrile: deionized water, and a UV-visible 
detector was employed (DAD Detector Signal (mAU) = 273/4 nm, Reference 360/80 
nm). A calibration using caffeine solutions of known concentration was performed. 
The retention time of caffeine in the column used for this study was approximately 
0.54 minutes.  
 
Where appropriate, cumulative masses were determined as the sum of the mass of 
permeated caffeine at a certain time point plus the mass at all previous time points; 
and fluxes were calculated as the mass of permeated caffeine divided by the time and 
the surface area of the 10 cm hollow fiber.  
 
2.6. Statistical analysis and data accessibility  
All the results are presented as the average value from three (N = 3) independent 
experiments and the error bars represent the standard deviation. One-tailed Student’s 
t-test at a 95 % confidence level was used to assess significant differences between 
independent samples where appropriate. The data that was generated is archived and 
can be accessed via the University of Bath Library (DOI to be confirmed).  
3. Results and Discussion  
3.1. Morphology and porosity of hollow fibers 
The hollow fiber’s surface at a magnification of X5,000 can be seen in Figure 2A, and 
the results shown here are consistent with the work by Argyle et al. [31]; pores of 
approximately 1 μm in diameter can be observed. The presence of a higher 
concentration of porogen would increase the number of pores per unit surface area 
[31]. Figure 2B (magnification of X60) shows the cross section of the PX40 hollow 
fiber. Its asymmetric structure shows the clear narrowing of pores from top to bottom. 
The outer surface is smooth with randomly distributed pores (as seen in Figure 2A), 
whereas the sub-structure consists of uniform macrovoids. It can also be seen that the 
cross section is not regular with respect to the thickness of the walls. This is due to 
variations in the wet spinning manufacture (particularly because of the position of the 
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needle through which water is circulated in order to create the hollow lumen of the 
fiber).  
 
Figure 2: SEM of PX40 hollow fiber. (A) Outer surface; (B) Cross section.  
Pores of approximately 1 μm in diameter can be observed on the outer surface of the fiber. The 
porous structure of the fiber’s wall is also evident in the image of its cross section. 
 
3.2. Caffeine permeation in hydrophobic and hydrophilic fibers for 2 hours 
The concentration of caffeine (7.5 mg ml-1) can be considered as an infinite dose, i.e., 
the time for all the caffeine in the dose to permeate through the porous hollow fiber is 
long enough to be regarded as infinite assuming that no blocking of the pores occurs. 
Infinite dose scenarios are commonly used in skin penetration assays, since they allow 
a maximum rate of absorption to be maintained over time, and it is therefore possible 
to calculate steady state parameters [38]. This study was initially conducted for 2 
hours to observe the initial moments of permeation before reaching steady state. The 
concentration profile of caffeine permeating through the porous outer surface of PX40 
hydrophobic hollow fibers is shown in Figure 3A, and that for hydrophilic hollow 
fibers can be seen in Figure 3B. Caffeine is carried through the lumen of the fibers by 
the external flow of deionized water via convection, simulating blood circulation.  
It is clear that the permeation rate over a period of two hours dramatically depends on 
the polarity of the surface of the membrane. In the case of hydrophobic fibers (Figure 
3A) the concentration of caffeine in the permeate remains roughly constant for 30 
minutes, and then increases until it reaches a plateau by the end of the experiment. For 
hydrophilic fibers (Figure 3B), the concentration of caffeine that permeates is initially 
(at 10 minutes) 200 times higher than that for hydrophobic fibers (~10 μg ml-1 versus 
~0.05 μg ml-1). The concentration is constant for approximately 20 minutes and then 
increases, reaching its maximum at circa 50 minutes. It is worth highlighting that the 
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maximum concentration achieved using hydrophilic fibers is ~285 times higher than 
the corresponding maximum concentration for hydrophobic fibers (~50 μg ml-1 versus 
~0.18 μg ml-1). The concentration of caffeine, in the permeate, in hydrophilic PX40 
decreases slowly after 60 minutes, and the trend observed in Figure 3B suggests that a 
plateau would be reached. These results are consistent with the relatively hydrophilic 
nature of caffeine (partition coefficient water/n-octanol logP = -0.55). 
 
 
Figure 3: Comparison of the concentration of caffeine in permeates after 2 hours 
(A) Hydrophobic fibers; (B) Hydrophilic fibers. Fittings of the experimental data 
to determine the steady state values are also shown, namely a third degree 
polynomial and a quadratic fit for the first (solid line) and second (dotted line) 
part of the curves respectively.  
(N = 3, Error bars represent the standard deviation of triplicates. Error bars that cannot be seen 
represent very small standard deviations). 
 
The experimental data in Figures 3 A and B can be used to obtain the steady state 
values of caffeine concentration (despite not being reached after 2 hours). It can be 
seen that the shapes of the curves are broadly comparable: they both consist of an 
initial lag phase, followed by an increase in concentration, and then a decrease; 
despite the differences in permeation times and rates, suggesting that the mechanisms 
of permeation are analogous regardless of the polarity of the fibers. A third order 
polynomial fitting was applied to the first part of both curves seen in Figures 3 A and 
3 B as the curve of best fit, when the concentration of caffeine increases, as follows: 
Ccaffeine = a0 +a1  t +a2  t
2 +a3  t
3
 Equation 4 
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Following this, the peaks of both curves and the consequent decay in concentration 
were modeled using a quadratic fitting, as the curve of best fit, according to Equation 
5: 
Ccaffeine = b0 +b1  t +b2  t
2
 Equation 5 
 
Where Ccaffeine is the concentration of caffeine (μg ml-1), a0 (μg ml-1), a1 (μg ml-1 h-1), 
a2 (μg ml-1 h-2), a3 (μg ml-1 h-3), b0 (μg ml-1), b1 (μg ml-1 h-1), and b2 (μg ml-1 h-2) are 
parameters for the fittings, and t is the time (h). 
 
Predicted values can be calculated fitting the data to the corresponding equations, 
using non-linear least square minimization. The resulting parameters for the fittings 
shown in Figures 3 A and 3 B can be seen in Table 3. It also includes the prediction of 
the steady state concentration of caffeine after a virtually infinite time (7 days) in 
order to test the validity of the experimental model proposed in Equations 4 and 5. 
 
Table 3: Fitting of experimental data for caffeine concentration for both 
hydrophobic and hydrophilic fibers. 
Type of Fiber Parameters 
Prediction of 
caffeine 
concentration 
after 7 days 
Measured 
caffeine 
concentration 
after 7 days 
Hydrophobic (Figure 3 A) 
b0 = -0.1522 
b1 = 0.006088 
b2 = -2.85 x 10
-5 
 0.07 μg ml-1 
(0.05  0.02) μg 
ml-1 (N = 3) 
Hydrophilic (Figure 3 B) 
b0 = 97.99 
b1 = -1.141 
b2 = 0.003769 
12.7 μg ml-1 
(10.5  0.8) μg 
ml-1 (N = 3) 
 
The predicted values shown in Table 3 were then confirmed experimentally. It was 
found that the experimental model slightly over-predicts the concentration of caffeine 
after 7 days. This may be due to the blocking of the pores with time. 
Differences when comparing the flux of caffeine through hydrophobic (Figure 4A) 
and hydrophilic (Figure 4B) fibers, and in the cumulative mass that is collected after 2 
hours (Figure 5) can be observed. Fluxes were calculated taking into account the 
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surface area of the hollow fiber, which has an average diameter of ~1 mm and a 
length of 10 cm. The fluxes in Figure 4 show practically identical trends as the ones 
seen in Figure 3 for the concentration of caffeine. The maximum flux achieved in 
hydrophobic PX40 was 0.15 μg cm-2 h-1, while the maximum flux for hydrophilic 
PX40 was 65 μg cm-2 h-1. In addition to this, Figure 4 shows the differences in flux 
when hollow fibers were used in a first and a second pass (after being cleaned and 
flushed). For hydrophobic fibers (Figure 4A) there are no significant differences 
between the flux in the first and second passes; in fact, they overlap at approximately 
50 minutes, although the flux is marginally smaller by the end of the experimental 
time in the second pass. On the other hand, significant differences can be seen 
between the flux in the first and second passes for hydrophilic fibers. The evolution of 
flux over time is similar for both first and second passes (relatively flat start followed 
by an increase and then a smooth decrease), as can be seen in Figure 4B, but the 
magnitude of the flux is noticeably different – the maximum flux in the first pass is 
almost 6 times higher than in the second pass. This fact suggests that hydrophilic 
fibers undergo irreversible blocking of the pores. 
 
Figure 4: Flux of caffeine in hydrophobic fibers (A) and hydrophilic fibers (B) 
for fresh membranes (first pass), and used membranes (second pass).  
(N = 3, Error bars represent the standard deviation of triplicates. Error bars that cannot be seen 
represent very small standard deviations). 
The same conclusion can be reached by observing the cumulative mass of caffeine 
that permeates in a first and second passes, as shown in Figure 5. The final cumulative 
mass after 2 hours in the first and second passes for hydrophobic fibers is statistically 
the same, whereas for hydrophilic fibers, the final cumulative mass is significantly 
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higher in the first pass than in the second pass (P-value = 0.0003, see Figures 5C and 
5D). 
 
Figure 5: Cumulative mass of caffeine in hydrophobic fibers (A) and hydrophilic 
fibers (B) in both a first and second passes. The significance of pore blocking 
after a second pass is shown for hydrophobic fibers (C) and hydrophilic fibers 
(D).  
(N = 3, Error bars represent the standard deviation of triplicates, *** p-value = 0.0003, 95 % 
Confidence). 
 
Concerning the possible fouling or blocking phenomena occurring in the porous 
structure of PX40 hollow fibers, membranes with hydrophilic surfaces are less 
susceptible to fouling [39]. This obviously depends on the polarity of the foulants. An 
increase in the hydrophilicity of the membrane surface is often used to reduce 
membrane fouling by organic pollutants and microorganisms. Due to the formation of 
hydrogen bonds, a thin layer of bounded water exists on the surface of the hydrophilic 
membrane. This layer can prevent or reduce undesirable adsorption or adhesion of the 
compounds on the membrane surface [39]. In the case of caffeine, we hypothesize 
that these hydrogen bonds due to the functional groups of the membrane surface can 
also be formed with the caffeine molecules, inducing blocking. 
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3.3. Caffeine permeation rates 
In order to determine the rate of permeation of caffeine through hydrophilic and 
hydrophobic PX40 hollow fibers, the permeation study was extended over 24 hours 
and the relative cumulative mass at every time point with respect to the cumulative 
mass at the initial time (1 hour) was calculated. A period of 24 hours was considered 
in this case since it constitutes the standard time for skin penetration assays [6]. These 
results are shown in Figure 6, together with a linear fitting in order to calculate the 
permeation rates, according to Equation 6 as follows: 
Cumulative Mass (t)
Cumulative Mass (t0 )
= a+ k t  
Equation 6 
Where a is a constant (dimensionless), k is the permeation rate (h-1) and t is the time 
(h). The parameter a is 0, since there is no permeation of caffeine at time 0. 
 
Figure 6: Permeation rate in both hydrophobic and hydrophilic fibers after 24 
hours.  
(N = 3, Error bars represent the standard deviation of triplicates). The discontinuous lines 
represent the 95 % confidence interval of the linear fittings. 
 
The permeation rate of caffeine in hydrophobic fibers was found to be 0.61±0.03 h-1, 
while the permeation rate in hydrophilic fibers was 1.63±0.01 h-1. This difference in 
caffeine permeation kinetics in hydrophobic and hydrophilic environments has been 
observed in the literature, when comparing caffeine permeation in skin that presented 
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hair follicles (which is considered as the preferential pathway for hydrophilic 
compounds, although there is some controversy in the literature surrounding this fact) 
and with no appendages at all [40, 41]. 
 
As far as the percentage of dose that permeates is concerned, in terms of cumulative 
mass in the permeate, for hydrophobic fibers, approximately 87.2 % of the caffeine 
dose did not penetrate the porous surface of the fiber; 0.2 % of the dose was collected 
after 24 h (permeated through the pores), and therefore 12.6 % of the initial dose was 
suspected to block the membrane. For hydrophilic fibers, both the percentage of the 
initial dose that permeated and that of blocking caffeine increased to 1.2 % and 35.2 
% respectively.  
 
The results in this work can be compared to in vivo caffeine skin penetration data. The 
in vivo results obtained by Otberg et al. [40, 41] showed penetration of caffeine into 
the blood is rapid, following topical application, detectable in the blood after only a 
few minutes and reaching its maximum after 1 hour, and is similar to the results 
shown here for hydrophilic fibers (Figure 3 B). Otberg et al. [40, 41] also 
demonstrated that caffeine penetration is faster in vivo rather than in vitro, probably 
due to the existent blood flow in vivo. Those conditions are appropriately mimicked 
by the hollow fibers in this study. On the other hand, the percentage of caffeine that 
permeates after 24 hours is lower than that reported in vivo (between 12.4 and 24.9 
%), mainly because of the blocking of the pores in the hollow fibers. 
 
Conclusions 
We have fabricated hollow fiber membranes using a novel material, ‘polystyrene’, 
and functionalized the surface properties of the fibers such that their polarity can be 
tailored according to their use.  Caffeine is a widely studied chemical in skin 
penetration assays and as a proof of concept study we have demonstrated that caffeine 
permeates hydrophilic polystyrene hollow fibers.  Having established that caffeine 
can penetrate the fibers, they will be appropriate in order to mimic permeation into 
and movement through skin capillaries. The presence of an artificial vasculature will 
help overcome some of the limitations of the current established models, namely the 
inclusion of fully functioning ‘vascular network’, which is essential for the clearance 
of absorbed compounds that occurs in an in vivo scenario. Their use as a surrogate for 
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capillary-based clearance in in vitro skin absorption studies will be the focus for 
further work. 
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Figure Captions 
Figure 1: Caffeine permeation bioreactor system set-up.  
(A) Technical drawing of the hollow fiber bioreactor, including all dimensions (in 
mm). (B) Two-dimensional view of the hollow fiber bioreactor. Arrows represent the 
flow of the different components. (C) Three-dimensional view of the hollow fiber 
bioreactor. The hollow fiber is placed within the inner glass tube. A single caffeine 
dose is introduced in the extra-capillary space. The outer glass tube constitutes the 
jacket through which water at 32 °C is recirculated in order to maintain a constant 
temperature. Deionized (DI) water is pumped within the lumen of the fiber, carrying 
the caffeine that permeates across its porous surface. The inset represents a frontal 
view.  
Figure 2: SEM of PX40 hollow fiber. (A) Outer surface; (B) Cross section.  
Pores of approximately 1 μm in diameter can be observed on the outer surface of the 
fiber. The porous structure of the fiber’s wall is also evident in the image of its cross 
section. 
Figure 3: Comparison of the concentration of caffeine in permeates after 2 hours (A) 
Hydrophobic fibers; (B) Hydrophilic fibers (N = 3, Error bars represent the standard 
deviation of triplicates). 
Figure 4: Flux of caffeine in hydrophobic fibers (A) and hydrophilic fibers (B) for 
fresh membranes (first pass), and used membranes (second pass) (N = 3, Error bars 
represent the standard deviation of triplicates). 
Figure 5: Cumulative mass of caffeine in hydrophobic fibers (A) and hydrophilic 
fibers (B) in both a first and second pass. The significance of pore blocking after a 
second pass is shown for hydrophobic fibers in (C) and hydrophilic fibers in (D) (N = 
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3, Error bars represent the standard deviation of triplicates, *** p-value = 0.0003, 95 
% Confidence). 
Figure 6: Permeation rate in both hydrophobic and hydrophilic fibers after 24 hours 
(N = 3, Error bars represent the standard deviation of triplicates). The discontinuous 
lines represent the 95 % confidence interval of the linear fittings. 
 
Table Captions 
Table 1: Table 1: Geometrical properties of dermal capillaries (adapted from [37]). 
Table 2: Table 2: Geometrical properties of PX40 hollow fibers. 
Table 3: Fitting of experimental data for caffeine concentration for both hydrophobic 
and hydrophilic fibers. 
 
References 
[1] S. Wiedersberg, R.H. Guy, Transdermal drug delivery: 30+ years of war and still 
fighting!, J. Control Release 190 (2014) 150-6. 
[2] OECD, Skin Absorption: In Vitro Method, in: OECD (Ed.) Test guideline 428, 
Paris, 2004. 
[3] OECD, Guidance document for the conduct of skin adsorption studies, in: OECD 
(Ed.) Series on Testing and Assessment. No 28, Environment Directorate, Paris, 2004. 
[4] SCCNFP, Basic criteria for the in-vitro assessment of dermal absorption of 
cosmetic ingrecients, in: SCCNFP (Ed.) Burssels, 2010. 
[5] FDA, Guidance for industry: SUPAC-SS In-vitro release testing and in-vivo 
bioequivalence documentation, in: CDER (Ed.) 1997. 
[6] D.A. Bucks, Skin structure and metabolism: Relevance to the design of cutaneous 
therapeutics, Pharm Res 1(4) (1984) 148-53. 
[7] U.F. Schaefer, S. Hansen, M. Schneider, J.L. Contreras, C.-M. Lehr, Models for 
Skin Absorption and Skin Toxicity Testing, in: C. Ehrhardt, K.-J. Kim (Eds.), Drug 
Absorption Studies: In Situ, In Vitro and In Silico Models (2007) 3-33. 
[8] R.P. Chilcott, Cutaneous anatomy and function, Principles and practice of skin 
toxicology  (2008) 1-16. 
[9] D. Howes, R. Guy, J. Hadgraft, J. Heylings, U. Hoeck, F. Kemper, H. Maibach, J.-
P. Marty, H. Merk, J. Parra, D. Rekkas, I. Rondelli, H. Schaefer, U. Taeuber, N. 
Verbiese, Methods for Assessing Percutaneous Absorption. The Report and 
Recommendations of ECVAM Workshop 13, Altern. Lab. Anim. 24 (1996) 81-106. 
Page 20 of 22 
[10] J.E. Riviere, K.F. Bowman, N.A. Monteiro-Riviere, On the definition of viability 
in isolated perfused skin preparations, Br. J. Dematol. 116 (1987) 739-741. 
[11] J.E. Riviere, K.F. Bowman, N.A. Monteiro-Riviere, L.P. Dix, M.P. Carver, The 
isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for 
percutaneous absorption and cutaneous toxicology studies, Fundam. Appl. Toxicol. 
7(3) (1986) 444-453. 
[12] J.E. Riviere, N.A. Monteiro-Riviere, The Isolated Perfused Porcine Skin Flap as 
an In Vitro Model for Percutaneous Absorption and Cutaneous Toxicology, Critical 
Reviews in Toxicology 21(5) (1991) 329-344. 
[13] D.R. Friend, In vitro skin permeation techniques, Journal of Controlled Release 
18 (1992) 235-248. 
[14] H. Tagami, Percutaneous Absorption and Principles of Corneotherapy/Skin Care, 
in: T. Krieg, D.R. Bickers, Y. Miyachi (Eds.), Therapy of Skin Diseases: A 
Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis, 
Springer Science & Business Media (2010) 57-61. 
[15] B. Illel, H. Schaefer, J. Wepierre, O. Doucet, Follicles play an important role in 
percutaneous absorption, Journal of Pharmaceutical Sciences 80(5) (1991) 424-427. 
[16] R.O. Potts, R. Guy, Predicting Skin Permeability, Pharmaceutical Research 9(5) 
(1992) 663-669. 
[17] A. Wilschut, W.F. ten Berge, P.J. Robinson, T.E. McKone, Estimating skin 
permeation. The validation of five mathematical skin permeation models, 
Chemosphere 30(7) (1995) 1275-96. 
[18] R.L. Bronaugh, R.F. Stewart, E.R. Congdon, A.L. Giles, Jr., Methods for in Vitro 
percutaneous absorption studies. I. Comparison with in Vivo results, Toxicol Appl 
Pharmacol 62(3) (1982) 474-480. 
[19] Q. Yang, R.H. Guy, Characterisation of skin barrier function using 
bioengineering and biophysical techniques, Pharmaceutical Research 32(2) (2014) 
445-457. 
[20] L. Chen, L. Han, G. Lian, Recent advances in predicting skin permeability of 
hydrophilic solutes, Adv Drug Deliv Rev 65(2) (2013) 295-305. 
[21] F.M. Williams, In vitro studies—how good are they at replacing in vivo studies 
for measurement of skin absorption?, Environmental toxicology and pharmacology 
21(2) (2006) 199-203. 
Page 21 of 22 
[22] I. Martin, D. Wendt, M. Heberer, The role of bioreactors in tissue engineering, 
TRENDS in Biotechnology 22(2) (2004) 80-86. 
[23] J.B. Chaudhuri, M.G. Davidson, M.J. Ellis, M.D. Jones, X. Wu, Fabrication of 
Honeycomb-Structured Poly(DL-lactide) and Poly[(DL-lactide)-co-glycolide)] Films 
and their Use as Scaffolds for Osteoblast-Like Cell Culture, Macromolecular 
Symposia 272(1) (2008) 52-57. 
[24] S.M. Morgan, S. Tilley, S. Perera, M.J. Ellis, J. Kanczler, J.B. Chaudhuri, R.O. 
Oreffo, Expansion of human bone marrow stromal cells on poly-(DL-lactide-co-
glycolide) (PDL LGA) hollow fibres designed for use in skeletal tissue engineering, 
Biomaterials 28(35) (2007) 5332-43. 
[25] A.J. Davidson, M.J. Ellis, J.B. Chaudhuri, A theoretical method to improve and 
optimize the design of bioartificial livers, Biotechnol Bioeng 106(6) (2010) 980-8. 
[26] A.J. Davidson, M.J. Ellis, J.B. Chaudhuri, A theoretical approach to zonation in a 
bioartificial liver, Biotechnol Bioeng 109(1) (2012) 234-43. 
[27] G. Gigliobianco, C.K. Chong, S. MacNeil, Simple surface coating of electrospun 
poly-L-lactic acid scaffolds to induce angiogenesis, J Biomater Appl 30(1) (2015) 50-
60. 
[28] M.J. Ellis, J.B. Chaudhuri, Poly(lactic-co-glycolic acid) hollow fibre membranes 
for use as a tissue engineering scaffold, Biotechnol Bioeng 96(1) (2007) 177-87. 
[29] H. Shearer, M.J. Ellis, S.P. Perera, J.B. Chaudhuri, Effects of common 
sterilization methods on the structure and properties of poly(D,L lactic-co-glycolic 
acid) scaffolds, Tissue Eng 12(10) (2006) 2717-27. 
[30] N. Wung, S.M. Acott, D. Tosh, M.J. Ellis, Hollow fibre membrane bioreactors 
for tissue engineering applications, Biotechnol Lett 36(12) (2014) 2357-66. 
[31] I.S. Argyle, M.P. Storm, M.J. Ellis, Common salt used as a pore forming agent in 
flat sheet and hollow fibre polymeric membrane synthesis (In Preparation),  (n.d.). 
[32] C.A. Moore, S.C. Wilkinson, P.G. Blain, M. Dunn, G.A. Aust, F.M. Williams, 
Percutaneous absorption and distribution of organophosphates (chlorpyrifos and 
dichlorvos) following dermal exposure and decontamination scenarios using in vitro 
human skin model, Toxicol Lett 229(1) (2014) 66-72. 
[33] C.A. Moore, S.C. Wilkinson, P.G. Blain, M. Dunn, G.A. Aust, F.M. Williams, 
Use of a human skin in vitro model to investigate the influence of 'every-day' clothing 
and skin surface decontamination on the percutaneous penetration of 
organophosphates, Toxicol Lett 229(1) (2014) 257-64. 
Page 22 of 22 
[34] K. Kellam, P. Altmeyer, Capillary blood cell velocity in human skin capillaries 
located perpendicularly to the skin surface: measured by a new laser Doppler 
anemometer, Microvascular research 52 (1996) 188-192. 
[35] J. Ostergren, B. Fagrell, Skin capillary blood cell velocity in man. Characteristics 
and reproducibility of the reactive hyperemia response, International journal of 
microcirculation, clinical and experimental 5(1) (1986) 37-51. 
[36] S.-F. Ng, J.J. Rouse, F.D. Sanderson, V. Meidan, G.M. Eccleston, Validation of a 
static Franz diffusion cell system for in vitro permeation studies, Aaps Pharmscitech 
11(3) (2010) 1432-1441. 
[37] K. Kretsos, G.B. Kasting, A geometrical model of dermal capillary clearance, 
Mathematical biosciences 208(2) (2007) 430-453. 
[38] J. Kielhorn, S. Melching-Kollmuß, I. Mangelsdorf, Environmental Health 
Criteria 325 - Dermal Absorption, in: WHO (Ed.) WHO, 2006. 
[39] V. Kochkodan, Reduction of Membrane Fouling by Polymer Surface 
Modification, in: N. Hilal, M. Khayet, C.J. Wright (Eds.), Membrane Modification: 
Technology and Applications, CRC Press Taylor & Francis Group, Boca Raton 
(2012) 41-76. 
[40] N. Otberg, A. Patzelt, U. Rasulev, T. Hagemeister, M. Linscheid, R. Sinkgraven, 
W. Sterry, J. Lademann, The role of hair follicles in the percutaneous absorption of 
caffeine, Br J Clin Pharmacol 65(4) (2008) 488-92. 
[41] S. Trauer, A. Patzelt, N. Otberg, F. Knorr, C. Rozycki, G. Balizs, R. Buttemeyer, 
M. Linscheid, M. Liebsch, J. Lademann, Permeation of topically applied caffeine 
through human skin--a comparison of in vivo and in vitro data, Br J Clin Pharmacol 
68(2) (2009) 181-6. 
 
